drugset / Trial / NCT00206297

The Effect of Prolonged Pramlintide Infusion in Pediatric Diabetes

NCT00206297

Phase 3 Completed 20 enrolled Baylor College of Medicine
RandomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to see if reducing the dose of insulin before a meal and giving both pramlintide and insulin as dual wave infusions will lower the chance of low blood sugars after a meal. In addition, the study will look at giving pramlintide as a basal infusion (a very low steady dose) for several hours

Timeline

Start
2003-10
Primary completion
Completion
2006-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Pramlintide Peptide Subcutaneous